Masterclass: AI in Drug Discovery for Novel Therapies - Headwinds and Tailwinds for Investors

We are at the cusp of the 4th Industrial Revolution, where advances in technology, medicine and science will significantly accelerate the development of new novel drugs, devices, services and our own overall personal well being and health status.

There's been $100 billion in investments by Big Tech in AI innovation and technology in healthcare and life sciences in the past few years.

Groundbreaking new technologies such as AI, Machine Learning, Deep Learning are intersecting with unprecedented advances in healthcare and life sciences research, dramatically reshaping drug discovery, drug development and personalized medicine.

Join this masterclass led Dr Martin Alexander Gershon as he takes you through the next chapter of drug discovery and development using AI technologies. Expect insights on: 

• AI promises to be a unique pivot point and game changer for drug discovery. How is the technology being viewed by industry and how can you lead by example to bring novel technologies to your company? 
• What deals in AI drug discovery represent new models of engagement for industry partners and how can you develop those partnerships? 
• What new companies are outstanding examples of the future? Learn how to “skate to where the puck is going” to be a great player.